AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

CASI Pharmaceuticals, Inc.

$0.13 -$0.69 (-84.22%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.14
Day Range
$0.13$0.14
Year Range
$0.05$2.13
Market Cap
2.67M
AVG Volume
6.96K
Trailing/Forward PE
-0.06/-
PEG ratio
0.04
Dividend Yield
-
Next Earnings Date
2026-09-18
Primary Exchange
Other OTCUS
Revenue (USD)
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q24.91M
26 Q14.91M
25 Q47.22M
25 Q33.08M
25 Q24.17M
25 Q16.24M
24 Q413.36M
24 Q37.79M
24 Q23.98M
24 Q13.41M
Net Income (USD)
-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-10.02M
26 Q1-10.02M
25 Q4-13.04M
25 Q3-10.88M
25 Q2-13.38M
25 Q1-10.75M
24 Q4-14.37M
24 Q3-8.39M
24 Q2-6.96M
24 Q1-9.53M
Operating Income (USD)
-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-8.04M
26 Q1-8.04M
25 Q4-11.65M
25 Q3-10.68M
25 Q2-11.12M
25 Q1-10.38M
24 Q4-12.91M
24 Q3-8.46M
24 Q2-8.79M
24 Q1-9.22M
EBITDA (USD)
-15M-10M-5M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-7.9M
26 Q1-7.9M
25 Q4-12.83M
25 Q3-10.11M
25 Q2-10.96M
25 Q1-9.65M
24 Q4-9.76M
24 Q3-7.15M
24 Q2-8.62M
24 Q1-8.4M
Cash Flows (USD)
00.250.50.75124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
EPS (USD)
-1-0.75-0.5-0.25024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.49
26 Q1-0.49
25 Q4-0.63
25 Q3-0.68
25 Q2-0.86
25 Q1-0.69
24 Q4-0.93
24 Q3-0.55
24 Q2-0.52
24 Q1-0.71
Expenses (USD)
05M10M15M20MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q212.05M
26 Q112.05M
25 Q415.35M
25 Q310.95M
25 Q212.77M
25 Q113.86M
24 Q415.58M
24 Q312.13M
24 Q211.62M
24 Q111.03M
Cash & Debt (USD)
020M40M60MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q23.77M
26 Q13.77M
25 Q45.63M
25 Q34.68M
25 Q26.76M
25 Q112.7M
24 Q416.09M
24 Q320.81M
24 Q212.73M
24 Q119.66M
Debt ratios
-1-0.500.524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Debt ratios by quarter
PeriodDebt ratios
26 Q2-0.95
26 Q1-0.88
25 Q4-0.5
25 Q3-0.35
25 Q2-0.32
25 Q1-0.16
24 Q4-0.18
24 Q30.06
24 Q2-0.23
24 Q10.04
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Margins by quarter
PeriodMargins
26 Q278.06%
26 Q178.06%
25 Q451.14%
25 Q322.96%
25 Q249.29%
25 Q158%
24 Q424.17%
24 Q351.91%
24 Q251.95%
24 Q152.98%
Return on Capital
-1000%-750%-500%-250%0%250%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Return on Capital by quarter
PeriodReturn on Capital
26 Q217.19%
26 Q117.19%
25 Q434.98%
25 Q338.06%
25 Q265.85%
25 Q1133.21%
24 Q4-776.34%
24 Q3-60.63%
24 Q2-77.21%
24 Q1-61.6%
Shares Outstanding
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Shares Outstanding by quarter
PeriodShares Outstanding
26 Q220.56M
26 Q120.56M
25 Q420.56M
25 Q316.05M
25 Q215.51M
25 Q115.49M
24 Q415.49M
24 Q315.29M
24 Q213.52M
24 Q113.38M
Book Value Per Share (USD)
-3-2-101224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q2-2.83
26 Q1-2.83
25 Q4-1.81
25 Q3-1.78
25 Q2-1.31
25 Q1-0.52
24 Q40.12
24 Q30.91
24 Q20.67
24 Q11.16
Total Assets (USD)
020M40M60M80M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CASIF Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q221.06M
26 Q121.06M
25 Q425.65M
25 Q324.46M
25 Q231.2M
25 Q140.82M
24 Q453.67M
24 Q363.62M
24 Q251.27M
24 Q158.01M
Employee Count
01002003002022202320242025
CASIF Employee Count by quarter
PeriodEmployee Count
2025214
2024233
2023243
2022224
Free Cash Flow Yield
0%0.25%0.5%0.75%1%med 0%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CASIF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 260%
Sep 260%
Sep 260%
Aug 260%
Aug 260%
Aug 260%
Aug 260%
Jul 260%
Jul 260%
Jul 260%
Jul 260%
Jul 260%
Jun 260%
Jun 260%
Jun 260%
Jun 260%
May 260%
May 260%
May 260%
May 260%
May 260%
Apr 260%
Apr 260%
Apr 260%
Apr 260%
Mar 260%
Mar 260%
Mar 260%
Mar 260%
Feb 260%
Feb 260%
Feb 260%
Feb 260%
Jan 260%
Jan 260%
Jan 260%
Jan 260%
Jan 260%
Dec 250%
Dec 250%
Dec 250%
Dec 250%
Nov 250%
Nov 250%
Nov 250%
Nov 250%
Oct 250%
Oct 250%
Oct 250%
Oct 250%
Oct 250%
Sep 250%
Sep 250%
Sep 250%
Sep 250%
Aug 250%
Aug 250%
Aug 250%
Aug 250%
Aug 250%
Jul 250%
Jul 250%
Jul 250%
Jul 250%
Jun 250%
Jun 250%
Jun 250%
Jun 250%
May 250%
May 250%
May 250%
May 250%
May 250%
Apr 250%
Apr 250%
Apr 250%
Apr 250%
Mar 250%
Mar 250%
Mar 250%
Mar 250%
Feb 250%
Feb 250%
Feb 250%
Feb 250%
Jan 250%
Jan 250%
Jan 250%
Jan 250%
Jan 250%
Dec 240%
Dec 240%
Dec 240%
Dec 240%
Nov 240%
Nov 240%
Nov 240%
Nov 240%
Nov 240%
Oct 240%
Price to Sales
01234med 0.7Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CASIF Price to Sales by quarter
PeriodPrice to Sales
Sep 260.13
Sep 260.14
Sep 260.16
Aug 260.13
Aug 260.13
Aug 260.15
Aug 260.14
Jul 260.14
Jul 260.14
Jul 260.18
Jul 260.15
Jul 260.16
Jun 260.13
Jun 260.17
Jun 260.2
Jun 260.13
May 260.12
May 260.11
May 260.15
May 260.08
May 260.09
Apr 260.08
Apr 260.08
Apr 260.09
Apr 260.07
Mar 260.07
Mar 260.09
Mar 260.09
Mar 260.13
Feb 260.14
Feb 260.46
Feb 260.51
Feb 260.55
Jan 260.61
Jan 260.57
Jan 260.57
Jan 260.66
Jan 260.49
Dec 250.47
Dec 250.48
Dec 250.52
Dec 250.57
Nov 250.61
Nov 250.74
Nov 250.75
Nov 250.68
Oct 250.71
Oct 250.81
Oct 250.85
Oct 250.97
Oct 250.91
Sep 250.64
Sep 250.87
Sep 251.12
Sep 251.15
Aug 251.13
Aug 251.17
Aug 251.18
Aug 250.81
Aug 250.64
Jul 250.73
Jul 250.62
Jul 250.69
Jul 250.64
Jun 250.65
Jun 250.72
Jun 251
Jun 251.01
May 251.03
May 251.02
May 251.05
May 251.03
May 251.06
Apr 251.11
Apr 251.05
Apr 251.06
Apr 251.13
Mar 251.49
Mar 251.53
Mar 251.55
Mar 251.53
Feb 251.56
Feb 251.7
Feb 251.73
Feb 251.71
Jan 251.72
Jan 251.84
Jan 251.82
Jan 251.81
Jan 252
Dec 241.74
Dec 241.55
Dec 241.82
Dec 242.12
Nov 242.22
Nov 242.98
Nov 243.12
Nov 243.21
Nov 243.52
Oct 243.8
Price to Book
05101520med 2.45Oct 23Jan 24May 24Aug 24Nov 24Mar 25Jun 25
CASIF Price to Book by quarter
PeriodPrice to Book
Jun 2510.04
Jun 2511.13
Jun 2515.4
Jun 2515.57
May 2515.82
May 2515.65
May 2516.24
May 2515.82
May 2516.32
Apr 2517.16
Apr 2516.24
Apr 2516.32
Apr 2517.49
Mar 252.37
Mar 252.44
Mar 252.46
Mar 252.43
Feb 252.49
Feb 252.71
Feb 252.76
Feb 252.72
Jan 252.74
Jan 252.94
Jan 252.89
Jan 252.88
Jan 253.18
Dec 244.47
Dec 243.97
Dec 244.66
Dec 245.44
Nov 245.69
Nov 247.64
Nov 247.99
Nov 248.21
Nov 249.01
Oct 249.74
Oct 248.36
Oct 248.72
Oct 248.29
Sep 245.2
Sep 245.6
Sep 246.2
Sep 245.62
Aug 245.7
Aug 245.58
Aug 245.68
Aug 245.42
Aug 245.79
Jul 245.71
Jul 245.49
Jul 245.39
Jul 244.96
Jun 243.04
Jun 242.03
Jun 241.72
Jun 241.92
May 242.14
May 241.97
May 241.83
May 241.47
May 241.55
Apr 241.34
Apr 241.25
Apr 241.44
Apr 241.77
Mar 242
Mar 240.81
Mar 240.84
Mar 241.29
Mar 241.46
Feb 241.47
Feb 241.54
Feb 241.66
Feb 241.67
Jan 241.86
Jan 241.27
Jan 241.61
Jan 241.77
Dec 231.9
Dec 231.58
Dec 231.52
Dec 231.74
Dec 231.39
Nov 231.45
Nov 231.14
Nov 231.09
Nov 231.18
Oct 230.9
Oct 230.78
Oct 230.65
Oct 230.67
Sep 230.63
Sep 230.46
Sep 230.45
Sep 230.46
Sep 230.46
Aug 230.52
Aug 230.5
Aug 230.5
Aug 230.5
CASI Pharmaceuticals, Inc.
CASIF
Stockpicker

Video analysis: CASIF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.